BELFAST centenarians: A case of optimal cardiovascular risk?

E. Bennati; A. Murphy; F. Cambien; A.S. Whitehead; G.P.R. Archbold; I.S. Young; I.M. Rea

doi:10.2174/138161210790883697

BELFAST centenarians: A case of optimal cardiovascular risk?

E. Bennati, A. Murphy, F. Cambien, A.S. Whitehead, G.P.R. Archbold, I.S. Young, I.M. Rea

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	789-795
Journal	Current Pharmaceutical Design
Volume	16
Issue number	7
DOIs	https://doi.org/10.2174/138161210790883697
Publication status	Published (in print/issue) - 2010

Bibliographical note

cited By 13

Keywords

ACE
Anti-oxidants
Apoe
BELFAST
Centenarians
Cholesterol
Malondiadehyde
Mortality

Access to Document

10.2174/138161210790883697

https://www.scopus.com/inward/record.uri?eid=2-s2.0-77950295357&doi=10.2174%2f138161210790883697&partnerID=40&md5=7201bb97a4f2e07829d4708aeb04ad9b

Cite this

@article{34a8d66e2dda4568a910d44f98d456d4,

title = "BELFAST centenarians: A case of optimal cardiovascular risk?",

keywords = "ACE, Anti-oxidants, Apoe, BELFAST, Centenarians, Cholesterol, Malondiadehyde, Mortality",

author = "E. Bennati and A. Murphy and F. Cambien and A.S. Whitehead and G.P.R. Archbold and I.S. Young and I.M. Rea",

note = "cited By 13",

year = "2010",

doi = "10.2174/138161210790883697",

language = "English",

volume = "16",

pages = "789--795",

journal = "Current Pharmaceutical Design",

issn = "1381-6128",